Shenandoah Oncology
Shenandoah Oncology is a community-based, integrated cancer center in Winchester, Virginia, delivering medical oncology, hematology, radiation oncology, and supportive services to cancer and blood disorder patients across Virginia, West Virginia, and Maryland as part of The US Oncology Network.
- Company typePrivate
- Founded1989
- HeadquartersWinchester, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Shenandoah Oncology does
Shenandoah Oncology is a privately held, community-based oncology practice founded in 1989 and headquartered at 400 Campus Blvd, Winchester, Virginia. It operates as the region's only integrated cancer center, delivering medical oncology, hematology, and radiation oncology services alongside on-site laboratory, pharmacy, genetic testing and counseling, tumor board review, patient navigation, nutritional counseling, oncology social work, and patient financial counseling. Treatment modalities span chemotherapy, immunotherapy (including CAR T-cell therapy and immune checkpoint inhibitors), hormone therapy, targeted therapy, palliative care, and stem cell transplantation, covering 24+ cancer types and benign hematologic conditions.
The practice serves individual patients across a four-state regional catchment spanning the Shenandoah Valley, Northern Virginia, Eastern West Virginia, and Western Maryland, including cities such as Harrisonburg, Leesburg, Martinsburg, and Hagerstown. Patient acquisition relies on physician referrals, patient self-referrals, second-opinion requests, and word-of-mouth, supported by a website, patient portal, and online referral system. Revenue is generated through professional services billed to insurance carriers and patients directly, with financial counseling provided to navigate coverage.
Shenandoah Oncology is a participating practice within The US Oncology Network, a national affiliation of more than 1,200 independent physicians supported by McKesson Corporation. Through this affiliation and direct partnerships with US Oncology Research and Sarah Cannon Research Institute, the practice provides patients access to community-based clinical trials that have contributed to over 100 FDA-approved cancer therapies. The clinical team comprises ten named board-certified physicians holding combined experience of more than 100 years, supported by advanced practice providers and skilled nursing staff.
Shenandoah Oncology firmographics
Firmographics- Name
- Shenandoah Oncology
- Legal name
- Shenandoah Oncology
- Website
- https://shenandoahoncology.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Shenandoah Oncology is a community-based, integrated cancer center in Winchester, Virginia, delivering medical oncology, hematology, radiation oncology, and supportive services to cancer and blood disorder patients across Virginia, West Virginia, and Maryland as part of The US Oncology Network.
- Ownership category
- akta.pro rank
Shenandoah Oncology industry classification
Industry- Product category
- Oncology Services
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
Keywords
Where Shenandoah Oncology is headquartered
LocationHeadquarters
- HQ city
- Winchester
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Shenandoah Oncology business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Patient Care Services: Healthcare services including medical oncology, hematology, radiation oncology, laboratory services, pharmacy, and supportive care. Billed to insurance or patients directly. Revenue generated through medical procedures, treatments, and clinical services.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Shenandoah Oncology product offering
Product offeringCore offering
Shenandoah Oncology is an independent, community-based integrated cancer center providing medical oncology, hematology, and radiation oncology services, along with chemotherapy, immunotherapy, hormone therapy, targeted therapy, clinical trials, and stem cell transplantation. It also offers on-site laboratory, pharmacy, genetic testing and counseling, tumor board review, patient navigation, nutritional counseling, oncology social services, and patient financial counseling. Care is delivered by board-certified specialists to patients across the Shenandoah Valley, Northern Virginia, Eastern West Virginia, and Western Maryland.
Product overview
Shenandoah Oncology is a unified cancer treatment center offering integrated oncology services through multiple specialized treatment modalities. The core offerings include Medical Oncology, Radiation Oncology, and Hematology services delivered by board-certified specialists. These are supported by a comprehensive suite of diagnostic and supportive services including Laboratory, Pharmacy, Genetic Testing & Counseling, and Patient Navigator programs. Treatment options span Chemotherapy & Biologics (Immunotherapy), Hormone Therapy, Targeted Therapy, and access to Clinical Trials Research through US Oncology Research. The center provides care across 24+ cancer types including breast, lung, colorectal, prostate, ovarian, melanoma, and blood cancers like leukemia and lymphoma. Additional supportive services include Palliative Care, Nutritional Counseling, Oncology Social Services, Tumor Board reviews, and Patient Financial Counseling.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Oncology Board-certified medical oncology specialists providing personalized cancer treatment plans including chemotherapy, immunotherapy, targeted therapy, and biologics for adult patients.
- Radiation Oncology State-of-the-art radiation therapy treatments including stereotactic body radiation therapy (SBRT) for precise tumor targeting, delivered by board-certified radiation oncologists.
- Hematology Specialty care for blood disorders and blood cancers including leukemia, lymphoma, multiple myeloma, and benign hematologic conditions.
- Chemotherapy and Biologics (Immunotherapy) Chemotherapy drugs and biologic therapies including monoclonal antibodies, CAR T-cell therapy, and immune checkpoint inhibitors to treat cancer.
- Hormone Therapy Hormone-blocking treatments for cancers that respond to hormone levels, including prostate and breast cancer treatments.
- Targeted Therapy Drugs that block specific gene mutations and molecular targets in cancer cells, including BTK inhibitors, proteasome inhibitors, and PARP inhibitors.
- Clinical Trials Research Access to groundbreaking clinical trials through US Oncology Research and Sarah Cannon Research Institute, offering promising new treatments before widespread availability.
- Laboratory Services On-site laboratory testing for diagnostics including blood tests, biopsies, and genetic testing.
- Pharmacy Services On-site pharmacy providing medications and pharmaceutical support for cancer treatment.
- Genetic Testing and Counseling Genetic counseling and testing for inherited cancer risk genes including BRCA1, BRCA2, and Lynch syndrome genes, plus genomic testing of tumor tissue.
- Tumor Board Multidisciplinary team review of cases to develop comprehensive treatment recommendations.
- Patient Navigator Guides patients through the cancer care journey with emotional support and assistance for families.
- Nutritional Counseling Dietitian services to support nutrition during cancer treatment.
- Oncology Social Services Social work services to support patients and families with cancer-related challenges.
- Patient Financial Counselor Financial counseling to help patients navigate insurance and treatment costs.
- Palliative Care Specialized care focused on relieving symptoms and improving quality of life for cancer patients.
- Stem Cell Transplantation Stem cell transplant services for eligible patients with blood cancers and multiple myeloma.
Companies that use Shenandoah Oncology
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
Shenandoah Oncology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Shenandoah Oncology partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- The US Oncology NetworkcoreShenandoah Oncology is a practice in The US Oncology Network, which unites more than 1,200 independent physicians dedicated to delivering value-based, integrated care to patients close to home. The Network provides shared expertise and resources dedicated to advancing local cancer care and delivering better patient outcomes.
- McKesson CorporationcoreThe US Oncology Network is supported by McKesson Corporation, whose coordinated resources and infrastructure allow doctors in The Network to focus on the health of their patients while McKesson focuses on the health of their practices.
- US Oncology ResearchcoreShenandoah Oncology participates in clinical trials through US Oncology Research, which has played a role in more than 100 FDA-approved cancer therapies, approximately one-third of all cancer therapies approved by the FDA to date.
- Sarah Cannon Research Institute (SCRI)coreShenandoah Oncology offers clinical trials through Sarah Cannon Research Institute, one of the world's leading oncology research organizations conducting community-based clinical trials. SCRI has contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Shenandoah Oncology competitors and assessment
Company assessmentEmerging players
- OneOncology: PE-backed community oncology partnership platform partnering with independent practices to provide scale, technology, and operational support. Comparable as a forward-looking platform model that Shenandoah's affiliation with US Oncology/McKesson resembles.
- American Oncology Network: PE-backed (Fortress) community oncology platform aggregating independent oncology practices. Comparable as a roll-up vehicle into which Shenandoah could be acquired or benchmarked, given shared focus on community oncology consolidation.
Direct peers
- Oncology Hematology Care (OHC): Independent community oncology and hematology practice in the Cincinnati region offering medical oncology, radiation oncology, infusion, and clinical trials. Comparable as a multi-site integrated community oncology group.
- Virginia Cancer Specialists: Large community oncology and hematology practice in Northern Virginia offering medical oncology, radiation oncology, and clinical trials. Directly comparable to Shenandoah as a multi-site Virginia community oncology group serving overlapping regional patient flow.
- Tennessee Oncology: Large community-based oncology practice offering medical oncology, radiation, infusion, and clinical trials across Tennessee. Closely comparable as a multi-site community oncology group providing integrated cancer care under one platform.
- New York Oncology Hematology: Community oncology and hematology practice providing medical oncology, radiation oncology, infusion, and clinical research. Comparable as a US Oncology Network affiliate offering the same integrated service model as Shenandoah.
- Florida Cancer Specialists & Research Institute: One of the largest independent community oncology practices in the U.S., offering medical oncology, hematology, radiation oncology, and clinical trials. Comparable as a multi-site, community-integrated oncology group with strong research participation.
- Texas Oncology: Largest US Oncology Network affiliate and the most directly comparable community oncology platform — multi-site, integrated medical/radiation oncology with research access through US Oncology Research, mirroring Shenandoah's service model and network affiliation.
Others
- Sarah Cannon Research Institute: Strategic research partner of Shenandoah Oncology and one of the world's leading community-based oncology research organizations. Comparable as an ecosystem participant whose clinical-trial pipeline directly shapes Shenandoah's service offering.
Regional players
- Willamette Valley Cancer Institute: US Oncology Network affiliate providing community-based medical oncology, radiation oncology, and clinical research in Oregon. Comparable as a US Oncology Network–aligned community practice with similar service mix.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Shenandoah Oncology social profiles
Digital presenceShenandoah Oncology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Shenandoah Oncology leadership team
Management profileNumber of profiles
Profiles10 records
Shenandoah Oncology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Shenandoah Oncology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Shenandoah Oncology
What does Shenandoah Oncology do?
Shenandoah Oncology is an independent, community-based integrated cancer center providing medical oncology, hematology, and radiation oncology services, along with chemotherapy, immunotherapy, hormone therapy, targeted therapy, clinical trials, and stem cell transplantation. It also offers on-site laboratory, pharmacy, genetic testing and counseling, tumor board review, patient navigation, nutritional counseling, oncology social services, and patient financial counseling. Care is delivered by board-certified specialists to patients across the Shenandoah Valley, Northern Virginia, Eastern West Virginia, and Western Maryland.
Is Shenandoah Oncology a public or private company?
Shenandoah Oncology is a private company. It is classified as corporate owned and is currently operating.
When was Shenandoah Oncology founded?
Shenandoah Oncology was founded in 1989. It employs 11 to 50 people.
Where is Shenandoah Oncology based?
Shenandoah Oncology is headquartered in Winchester, United States, in the North America region.
How does Shenandoah Oncology make money?
One revenue line is on record: patient Care Services.
Who are Shenandoah Oncology's main competitors?
Emerging players on record are OneOncology and American Oncology Network. Direct peers are Oncology Hematology Care (OHC), Virginia Cancer Specialists, Tennessee Oncology, New York Oncology Hematology, Florida Cancer Specialists & Research Institute and Texas Oncology. Sarah Cannon Research Institute is listed as an others. Willamette Valley Cancer Institute is listed as a regional player.
Does Shenandoah Oncology have an API?
No public API is recorded for Shenandoah Oncology.
What industry is Shenandoah Oncology in?
Shenandoah Oncology's product category is Oncology Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 62111 and its SIC code is 8011.